Merck: Company Fact Sheet

Ticker Name MRK The company is known as Merck in the United States and Canada. Everywhere else, we are known as MSD. Merck & Co., Inc. remains the name of the publicly traded company. It also is the formal legal entity name of our holding company, which has operating companies under it. Today's Merck is an innovative, global healthcare leader that is committed to improving health and well-being around the world. The merger of Merck and Schering-Plough greatly expanded our combined company's product offerings in a range of areas, including heart and respiratory health, infectious diseases, sun care and womens health. And we continue to focus our research on conditions that affect millions of people around the world diseases like Alzheimers, diabetes and cancer while expanding our strengths in areas like vaccines and biologics. We also devote extensive time and energy to increasing access to medicines and vaccines through far-reaching programs that donate and deliver our products to the people who need them. At todays Merck, were applying our global reach, financial strength and scientific excellence to do more of what were passionate about: improving health and improving lives. Merck. Be Well. Employees Headquarters Businesses Approximately 93,000 employees worldwide (as of 3/31/2011) Whitehouse Station, New Jersey Pharmaceuticals Vaccines Consumer Care Animal Health Merck $45.6 billion

Description

2010 GAAP Revenue 2010 Revenues (By Geographic Region)

Merck United States Europe, Middle East and Africa Japan Other Merck

$20.2 billion $12.1 billion $3.6 billion $9.9 billion $10.9 billion

2010 R&D Expense

Note: Numbers may not add due to rounding

1 of 2

Merck: Company Fact Sheet

Products

Merck is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, and consumer and animal health products. For a list of products marketed in the U.S., visit http://www.merck.com/product/home.html. If you are a resident of a country other than the United States, go to www.merck.com and click on our "Worldwide Locator" in the upper righthand corner to find our Web sites in your country.

Pipeline

Merck has a robust pipeline, with a wide range of product candidates across each phase of development. To view our pipeline, visit http://www.merck.com/research/pipeline/home.html. Kenneth C. Frazier, president and chief executive officer Richard S. Bowles III, Ph.D., executive vice president and chief compliance officer Willie A. Deese, executive vice president and president, Merck Manufacturing Division Mirian M. Graddick-Weir, executive vice president, Human Resources Bridgette P. Heller, executive vice president and president, Consumer Health Care Peter N. Kellogg, executive vice president and chief financial officer Peter S. Kim, Ph.D., executive vice president and president, Merck Research Laboratories Raul E. Kohan, executive vice president and president, Animal Health Bruce N. Kuhlik, executive vice president and general counsel Michael Rosenblatt, M.D., executive vice president and chief medical officer J. Chris Scalet, executive vice president, Global Services, and chief information officer Adam H. Schechter, president, Global Human Health Mervyn Turner, Ph.D., chief strategy officer and senior vice president, Emerging Markets R&D, Merck Research Laboratories

Executive Committee

2 of 2